title: Damage control in the management of ruptured abdominal aortic aneurysm: preliminary results.
abstract: BACKGROUND
  This study compared damage control measures (DCM), including operative techniques (DCO) and resuscitative measures (DCR), with standard treatment (ST) for ruptured abdominal aortic aneurysm (rAAA).
  
  
  METHODS
  Historical cohort study methodology was used to evaluate outcomes for rAAA repairs related to DCM or ST over a 74-month period at a level I trauma center.
  
  
  RESULTS
  Of 28 repairs, 13 (46.4%) were DCM. Compared to ST patients, DCM patients had a lower mean preoperative BP (64.6 vs. 83.2 mm Hg, P = .03) and greater intraoperative blood loss (4.6 vs. 2.1 liters, P = .033). Patients who had both DCR and DCO (DCO & DCR) received more plasma (6.8 vs 2.6 units, P = .039) and less crystalloid (2.8 vs 10.5 liters, P = .005) than those receiving DCO only. A modest decrease in mortality was seen in the DCO & DCR group compared to DCO only. No DCO-related graft infections were observed.
  
  
  CONCLUSIONS
  DCR use may prove beneficial in the management of rAAA.
authors.affiliation: Trauma Service, Scripps Mercy Hospital, San Diego, CA, USA.
authors.forename: Matthew D
authors.initials: MD
authors.lastname: Tadlock
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Sise
authors.forename: Steven T
authors.initials: ST
authors.lastname: Riccoboni
authors.forename: C Beth
authors.initials: CB
authors.lastname: Sise
authors.forename: Daniel I
authors.initials: DI
authors.lastname: Sack
authors.forename: Robert G
authors.initials: RG
authors.lastname: Sise
authors.forename: Jack C
authors.initials: JC
authors.lastname: Yang
authors.forename: Jeffrey J
authors.initials: JJ
authors.lastname: Borut
authors.forename: Bryan S
authors.initials: BS
authors.lastname: King
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D017544:Aortic Aneurysm, Abdominal / Q000401:mortality / Q000503:physiopathology / Q000601:surgery / Q000628:therapy*; D001019:Aortic Rupture / Q000401:mortality / Q000503:physiopathology / Q000601:surgery / Q000628:therapy*; D016913:Blood Component Transfusion; D016063:Blood Loss, Surgical / Q000517:prevention & control; D001794:Blood Pressure; D016009:Chi-Square Distribution; D000077324:Crystalloid Solutions; D004739:England; D005260:Female; D006801:Humans; D007552:Isotonic Solutions / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D010043:Outcome and Process Assessment, Health Care; D010865:Pilot Projects; D012151:Resuscitation / Q000009:adverse effects / Q000401:mortality; D012189:Retrospective Studies; D018570:Risk Assessment; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome; D014656:Vascular Surgical Procedures / Q000009:adverse effects / Q000401:mortality
chemical_list: D000077324:Crystalloid Solutions; D007552:Isotonic Solutions